ALTMAN MICHAEL SETH
CIK: 0001746738•Chief Financial Officer
OfficerDirector10% Owner
Primary company: Nautilus Biotechnology, Inc. (NAUT)
ALTMAN MICHAEL SETH is a corporate insider (Chief Financial Officer) at Nautilus Biotechnology, Inc. (NAUT) filing SEC Form 4 transactions. 21 transactions across 6 companies. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Freenome, Inc. FRNM | Conversion | 2,066,250 | - | - | 0 | 7/20/2026 Filed: 7/20/2026 | Filing → |
Freenome, Inc. FRNM | Conversion | 2,066,250 | - | - | 2,352,500 | 7/20/2026 Filed: 7/20/2026 | Filing → |
ARYA Sciences Acquisition Corp IV ARYD | Disposition | 2,647,500 | - | - | 0 | 7/31/2024 Filed: 7/31/2024 | Filing → |
ARYA Sciences Acquisition Corp IV ARYD | Disposition | 1,000,000 | - | - | 2,647,500 | 7/31/2024 Filed: 7/31/2024 | Filing → |
ARYA Sciences Acquisition Corp IV ARYD | Disposition | 499,000 | - | - | 0 | 7/31/2024 Filed: 7/31/2024 | Filing → |
| Award | 45,000 | - | - | 45,000 | 6/14/2024 Filed: 6/17/2024 | Filing → | |
| Award | 30,000 | - | - | 30,000 | 6/13/2024 Filed: 6/14/2024 | Filing → | |
Perceptive Capital Solutions Corp PCSC | Award | 286,250 | $10.00 | $2.86M | 286,250 | 6/13/2024 Filed: 6/13/2024 | Filing → |
| Award | 20,000 | $0.00 | $0 | 20,000 | 6/30/2023 Filed: 7/5/2023 | Filing → | |
| Award | 45,000 | $0.00 | $0 | 45,000 | 6/15/2023 Filed: 6/20/2023 | Filing → | |
| Award | 7,250 | $0.00 | $0 | 7,250 | 6/16/2022 Filed: 6/21/2022 | Filing → | |
| Award | 86,467 | $0.00 | $0 | 86,467 | 6/15/2022 Filed: 6/17/2022 | Filing → | |
ARYA Sciences Acquisition Corp V ARYE | Award | 499,000 | $10.00 | $4.99M | 499,000 | 7/15/2021 Filed: 7/15/2021 | Filing → |
Nautilus Biotechnology, Inc. [NAUT] | Award | 44,435 | $0.00 | $0 | 44,435 | 6/9/2021 Filed: 6/11/2021 | Filing → |
Nautilus Biotechnology, Inc. [NAUT] | Conversion | 3,647,500 | - | - | 0 | 6/9/2021 Filed: 6/11/2021 | Filing → |
Nautilus Biotechnology, Inc. [NAUT] | Conversion | 499,000 | - | - | 499,000 | 6/9/2021 Filed: 6/11/2021 | Filing → |
Nautilus Biotechnology, Inc. [NAUT] | Conversion | 499,000 | - | - | 0 | 6/9/2021 Filed: 6/11/2021 | Filing → |
Nautilus Biotechnology, Inc. [NAUT] | Conversion | 3,647,500 | - | - | 3,647,500 | 6/9/2021 Filed: 6/11/2021 | Filing → |
| Award | 7,250 | $0.00 | $0 | 7,250 | 5/26/2021 Filed: 5/28/2021 | Filing → | |
ARYA Sciences Acquisition Corp IV ARYD | Award | 499,000 | $10.00 | $4.99M | 499,000 | 3/2/2021 Filed: 3/2/2021 | Filing → |
Freenome, Inc.
FRNM
Type
Conversion
Shares
2,066,250
Price
-
Value
-
Freenome, Inc.
FRNM
Type
Conversion
Shares
2,066,250
Price
-
Value
-
ARYA Sciences Acquisition Corp IV
ARYD
Type
Disposition
Shares
2,647,500
Price
-
Value
-
ARYA Sciences Acquisition Corp IV
ARYD
Type
Disposition
Shares
1,000,000
Price
-
Value
-
ARYA Sciences Acquisition Corp IV
ARYD
Type
Disposition
Shares
499,000
Price
-
Value
-
Type
Award
Shares
45,000
Price
-
Value
-
Type
Award
Shares
30,000
Price
-
Value
-
Perceptive Capital Solutions Corp
PCSC
Type
Award
Shares
286,250
Price
$10.00
Value
$2.86M
Type
Award
Shares
20,000
Price
$0.00
Value
$0
Type
Award
Shares
45,000
Price
$0.00
Value
$0
Type
Award
Shares
7,250
Price
$0.00
Value
$0
Type
Award
Shares
86,467
Price
$0.00
Value
$0
ARYA Sciences Acquisition Corp V
ARYE
Type
Award
Shares
499,000
Price
$10.00
Value
$4.99M
Nautilus Biotechnology, Inc.
[NAUT]
Type
Award
Shares
44,435
Price
$0.00
Value
$0
Nautilus Biotechnology, Inc.
[NAUT]
Type
Conversion
Shares
3,647,500
Price
-
Value
-
Nautilus Biotechnology, Inc.
[NAUT]
Type
Conversion
Shares
499,000
Price
-
Value
-
Nautilus Biotechnology, Inc.
[NAUT]
Type
Conversion
Shares
499,000
Price
-
Value
-
Nautilus Biotechnology, Inc.
[NAUT]
Type
Conversion
Shares
3,647,500
Price
-
Value
-
Type
Award
Shares
7,250
Price
$0.00
Value
$0
ARYA Sciences Acquisition Corp IV
ARYD
Type
Award
Shares
499,000
Price
$10.00
Value
$4.99M
AI Agent
Try asking...